The control of plant diseases caused by fungal plant pathogens is extremely important in achieving high crop efficiency. Plant disease damage to ornamental, vegetable, field, cereal, and fruit crops can cause significant reduction in productivity and thereby result in increased costs to the consumer. Many products are commercially available for these purposes, but the need continues for new compounds, which are more effective, less costly, less toxic, environmentally safer or have different modes of action.

WO 01/11966 discloses certain pyridinyl amides of formula i as fungicides wherein, among others, A1 is 2-pyridyl substituted by up to four groups at least one of which is haloalkyl ; A2 is optionally substitted heterocyclyl; Ri and R2 are independently H, alkyl or acyl ; R3 is H or alkyl ; and L is- (C=O)-,-S02-or- (C=S)-.

Fungicides that effectively control plant fungi, particularly of the class Oomycetes, such as Pkvtophthora spp. and Plasmopara spp. , are in constant demand by growers.

Combinations of fungicides are often used to facilitate disease control and to retard resistance development. It is desirable to enhance the activity spectrum and the efficacy of disease control by using mixtures of active ingredients that provide a combination of curative, systemic and preventative control of plant pathogens. Also desirable are combinations that provide greater residual control to allow for extended spray intervals. It is also very desirable to combine fungicidal agents that inhibit different biochemical pathways in the fungal pathogens to retard development of resistance to any one particular plant disease control agent.

It is in all cases particularly advantageous to be able to decrease the quantity of chemical agents released in the environment while ensuring effective protection of crops from diseases caused by plant pathogens. Mixtures of fungicides may provide significantly better disease control than could be predicted based on the activity of the individual components. This synergism has been described as"the cooperative action of two components of a mixture, such that the total effect is greater or more prolonged than the sum

of the effects of the two (or more) taken independently" (see Tames, P. M. L., Nets. J. Plant Pathology, (1964), 70, 73-80).

There is a desire to find fungicidal agents that are particularly advantageous in achieving one or more of the preceding objectives.

SUMMARY OF THE INVENTION This invention relates to compounds of Formula I (including all geometric and stereoisomers), N-oxides, and agriculturally suitable salts thereof : wherein RI and R2 are each independently H or C1-C6 alkyl ; X and either Y or Z are a linking chain 3 or 4 atoms in length attached to contiguous carbon atoms and are taken together with said carbon atoms to form a fused phenyl ring, a fused 5-or 6-membered nonaromatic carbocyclic or heterocyclic ring optionally including one or two ring members selected from the group consisting of C (=O), SO and S (O) 2, or a fused 5-or 6-membered heteroaromatic ring, each fused ring optionally substituted with one to three substituents independently selected from R7 ; each R5 is independently C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, C02H, CONH2, N02, hydroxy, C1-C4 alkoxy, Cl-C4 haloalkoxy, C1-C4 alkylthio, Cl-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylamino, C2-C8 diallcylamino, C3-C6 cycloalkylamino, C2-C6 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-Cg dialkylaminocarbonyl or C3-C6 trialkylsilyl ; each R6 is independently Cl-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, C02H, CONH2, NO2, hydroxy, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsufinyl, C1-C4 alkylsulfonyl, Cl-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylamino, C2-C8 dialkylamino, C3-C6 cycloalkylamino, C2-C6 alkylcarbonyl,

C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, Cg-Cg dialkylaminocarbonyl or C3-C6 trialkylsilyl ; each R7is independently C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, Cl-C4 haloalkyl, C2-C4 haloalkenyl, C2-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, N02, Cl-C4 alkoxy, Cl-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, Cl-C4 alkylamino, C2-Cg dialkylamino, C3- C6 cycloalkylamino, C3-C6 (alkyl) cycloalkylamino, C2-C4 alkylcarbonyl, C2-C6 alkoxyvarbonyl, C2-C6 aLkylaminocarbonyl, C3-C8 dialkylaminocarbonyl or C3- C6 trialkylsilyl ; m is 1,2, 3 or 4; and pis0, 1, or2.

This invention also relates to fungicidal compositions comprising fungicidally effective amounts of the compounds of the invention and at least one additional component selected from the group consisting of surfactants, solid diluents, liquid diluents and other fungicides.

For example, this invention provides compositions comprising (a) at least one compound of Formula I ; and (b) at least one compound selected from the group consisting of (bl) alkylenebis (dithiocarbamate) fungicides; (b2) compounds acting at the bc, complex of the fungal mitochondrial respiratory electron transfer site; (b3) cymoxanil; (b4) compounds acting at the demethylase enzyme of the sterol biosynthesis pathway; (b5) morpholine and piperidine compounds that act on the sterol biosynthesis pathway; (b6) phenylamide fungicides; (b7) pyrimidinone fungicides; (b8) phthalimides; and (b9) fosetyl-aluminum.

This invention also relates to a method for controlling plant diseases caused by fungal plant pathogens comprising applying to the plant or portion thereof, or to the plant seed or seedling, a fungicidally effective amount of a compound or composition of the invention.

DETAILS OF THE INVENTION In the above recitations, the term."alkyl", used either alone or in compound words such as"alkylthio"or"haloalkyl"includes straight-chain or branched alkyl, such as, methyl, ethyl, n-propyl, i-propyl, or the different butyl, pentyl or hexyl isomers."Alkenyl"includes straight chain or branched alkenes such as ethenyl, 1-propenyl, 2-propenyl, and the different butenyl, pentenyl and hexenyl isomers."Alkenyl"also includes polyenes such as 1,2-propadienyl and 2, 4-hexadienyl."Alkynyl"includes straight chain or branched alkynes

such as ethynyl, 1-propynyl, 2-propynyl and the different butynyl, pentynyl and hexynyl isomers."Alkynyl"can also include moieties comprised of multiple triple bonds such as 2, 5-hexadiynyl."Alkoxy"includes, for example, methoxy, ethoxy, n-propyloxy, isopropyloxy and the different butoxy, pentoxy and hexyloxy isomers."Alkoxyalkyl" denotes alkoxy substitution on alkyl. Examples of"alkoxyalkyl"include CH3OCH2, CH30CH2CH2, CH3CH20CH2, CH3CH2CH2CH20CH2 and CH3CH2OCH2CH2.

"Alkoxyalkoxy" denotes alkoxy substitution on alkoxy. The term"Alkenyloxy"includes straight chain or branched alkenyloxy moieties. Examples of"alkenyloxy"include H2C=CHCH20, (CH3) 2C=CHCH20, (CH3) CH=CHCH20, (CH3) CH=C (CH3) CH20 and CH2=CHCH2CH2O. "Alkynyloxy" includes straight chain or branched alkynyloxy moieties. Examples of "alkynyloxy" include HC#CCH2O, CH3C#CCH2O and CHgC=CCH2CH20."Alkylthio"includes branched or straight chain alkylthio moieties such as methylthio, ethylthio, and the different propylthio, butylthio, pentylthio and hexylthio isomers. "Alkylthioalkyl" denotes alkylthio substitution on alkyl. Examples of "aLkylthioaLkyl"include CH3SCH2, CH3SCH2CH2, CH3CH2SCH2, CH3CH2CH2CH2SCH2 and CH3CH2SCH2CH2."Alkylthioalkoxy"denotes alkylthio substitution on alkoxy.

"Alkylsulfinyl" includes both enantiomers of an alkylsulfinyl group. Examples of "alkylsulfinyl"include CH3S (O), CH3CH2S (O), CH3CH2CH2S (O), (CHg) 2CHS (O) and the different butylsulfinyl, pentylsulfinyl and hexylsulfinyl isomers. Examples of "alkylsulfonyl"include CH3S (0) 2, CH3CH2S (0) 2, CH3CH2CH2S (0) 2, (CH3) 2CHS (o) 2 and the different butylsulfonyl, pentylsulfonyl and hexylsulfonyl isomers."Cyanoalkyl" denotes an alkyl group substituted with one cyano group. Examples of"cyanoalkyl"include NCCH2, NCCH2CH2 and CH3CH (CN) CH2."Alkylamino","dialkylamino","alkenylthio", "alkenylsulfmyl","alkenylsulfonyl","allcynylthio","alkynylsu lfinyl","alkynylsulfonyl", and the like, are defined analogously to the above examples."Cycloallcyl"includes, for example, cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. The term"cycloalkoxy" includes the same groups linked through an oxygen atom such as cyclopentyloxy and cyclohexyloxy.

The term"halogen", either alone or in compound words such as"haloalkyl", includes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as "haloalkyl", said alkyl may be partially or fully substituted with halogen atoms which may be the same or different. Examples of"haloalkyl"include F3C, C1CH2, CF3CH2 and CF3CCl2. The terms"haloalkenyl","haloalkynyl","haloalkoxy","haloalkylthio ", and the like, are defined analogously to the term"haloalkyl". Examples of"haloalkenyl"include (Cl) 2C=CHCH2 and CF3CH2CH=CHCH2. Examples of "haloalkynyl" include HC#CCHCl3, CF3C#C, CCl3C#C and FCH2C---CCH2. Examples of"haloalkoxy"include CF30, CC13CH20, HCF2CH2CH20 and CF3CH20. Examples of"haloalkylthio"include CC13S, CF3S, CC13CH2S and CICH2CH2CH2S. Examples of"haloalkylsulfinyl"include CF3S (O),

CCl3S (O), CF3CH2S (O) and CF3CF2S (O). Examples of"haloalkylsulfonyl"include CF3S (0) 2, CC13S (0) 2, CF3CH2S (0) 2 and CF3CF2S (O)2. Examples of "haloalkoxyalkoxy" include CF30CH20, ClCH2CH2OCH2CH2O, C13CCH20CH20 as well as branched alkyl derivatives. Examples of"alkylcarbonyl"include C (O) CH3, C (O) CH2CH2CH3 and C (O) CH (CH3) 2. Examples of"alkoxycarbonyl"include CH30C (=O), CH3CH2OC(=O), CH3CH2CH20C (=O), (CH3) 2CHOC (=O) and the different butoxy-or pentoxycarbonyl isomers.

"Aromatic"indicates that each of the ring atoms is essentially in the same plane and has ap-orbital perpendicular to the ring plane, and in which (4n + 2) z electrons, when n is 0 or a positive integer, are associated with the ring to comply with Hückel's rule. The term "aromatic carbocyclic ring"includes fully aromatic carbocycles (e. g. phenyl). The term "nonaromatic carbocyclic ring"denotes fully saturated carbocycles as well as partially or fully unsaturated carbocycles where the Huckel rule is not satisfied. The term"hetero"in connection with rings refers to a ring in which at least one ring atom is not carbon and which can contain 1 to 4 heteroatoms independently selected from the group consisting of nitrogen, oxygen and sulfur, provided that each ring contains no more than 4 nitrogens, no more than 2 oxygens and no more than 2 sulfurs. The terms"heteroaromatic ring includes fully aromatic heterocycles. The term"nonaromatic heterocyclic ring"denotes fully saturated heterocycles as well as partially or fully unsaturated heterocycles where the Huckel rule is not satisfied. The heterocyclic ring can be attached through any available carbon or nitrogen by replacement of a hydrogen on said carbon or nitrogen.

One skilled in the art will appreciate that not all nitrogen containing heterocycles can form N-oxides since the nitrogen requires an available lone pair for oxidation to the oxide; one skilled in the art will recognize those nitrogen containing heterocycles which can form N-oxides. One skilled in the art will also recognize that tertiary amines can form N-oxides.

Synthetic methods for the preparation of N-oxides of heterocycles and tertiary amines are very well known by-one skilled in the art including the oxidation of heterocycles and tertiary amines with peroxy acids such as peracetic and m-chloroperbenzoic acid (MCPBA), hydrogen peroxide, alkyl hydroperoxides such as t-butyl hydroperoxide, sodium perborate, and dioxiranes such as dimethydioxirane. These methods for the preparation of N-oxides have been extensively described and reviewed in the literature, see for example: T. L. Gilchrist in Comprehensive Organic Synthesis, vol. 7, pp 748-750, S. V. Ley, Ed., Pergamon Press; M. Tisler and B. Stanovnik in Comprehensive Heterocyclic Chemistry, vol.

3, pp 18-20, A. J. Boulton and A. McKillop, Eds., Pergamon Press; M. R. Grimmett and B. R. T. Keene in Advances in Heterocyclic Chemistry, vol. 43, pp 149-161, A. R. Katritzky, Ed. , Academic Press; M. Tisler and B. Stanovnik in Advances iel Heterocyclic Chemistry, vol. 9, pp 285-291, A. R. Katritzky and A. J. Boulton, Eds. , Academic Press; and

G. W. H. Cheeseman and E. S. G. Werstiuk in Advances in Heterocyclic Chemistly, vol. 22, pp 390-392, A. R. Katritzky and A. J. Boulton, Eds. , Academic Press.

The total number of carbon atoms in a substituent group is indicated by the"Ci-Cj" prefix where i and j are numbers from I to 8. For example, Cl-C3 alkylsulfonyl designates methylsulfonyl through propylsulfonyl; C2 alkoxyalkyl designates CH30CH2 ; C3 alkoxyalkyl designates, for example, CH3CH (OCHg), CH30CH2CH2 or CH3CH20CH2 ; and C4. alkoxyalkyl designates the various isomers of an alkyl group substituted with an alkoxy group containing a total of four carbon atoms, examples including CH3CH2CH20CH2 and CH3CH20CH2CH2.

When a compound is substituted with a substituent bearing a subscript that indicates the number of said substituents can exceed 1, said substituents (when they exceed 1) are independently selected from the group of defined substituents. Further, when the subscript indicates a range, e. g. (R) ij, then the number of substituents may be selected from the integers between i and j inclusive.

The term"optionally substituted with from one to three substituents"and the like indicates that one to three of the available positions on the group may be substituted. When a group contains a substituent which can be hydrogen, for example RI or R2, then when this substituent is taken as hydrogen, it is recognized that this is equivalent to said group being unsubstituted.

Compounds of Formula I can exist as one or more stereoisomers. The various stereoisomers include enantiomers, diastereomers, atropisomers and geometric isomers. One skilled in the art will appreciate that one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other stereoisomer (s) or when separated from the other stereoisomers). Additionally, the skilled artisan knows how to separate, enrich, and/or to selectively prepare said stereoisomers. Accordingly, the present invention comprises compounds selected from Formula I, N-oxides and agriculturally suitable salts thereof. The compounds of Formula I may be present as a mixture of stereoisomers, individual stereoisomers, or as an optically active form. In particular, when RI and R2 of Formula I are different, then said Formula possesses a chiral center at the carbon to which RI and R2 are commonly bonded.

This invention includes racemic mixtures of equal parts of Formula I'and Formula I".

wherein A is a 2-pyridinyl group substituted with (R5) m and B is a 3-pyridinyl group substituted with X and either Y or Z, and (R6) p, and X, Y or Z, R5, R6, m and p are as defined above.

In addition, this invention includes compounds and compositions that are enriched compared to the racemic mixture in an enantiomer of the Formula I'or Formula I". Included are compounds and compositions involving the essentially pure enantiomers of Formula I'or Formula I". For example, this invention includes compounds of Formula I that are enriched in an enantiomer of the Formula I'compared to the racemic mixture. Included are the essentially pure enantiomers of Formula I'. This invention also includes compositions wherein component (a) is enriched in a component (a) enantiomer of Formula I'compared to the racemic mixture. This invention also includes compounds of Formula I that are enriched in an enantiomer of the Formula I"compared to the racemic mixture. Included are the essentially pure enantiomers of Formula I". This invention also includes compositions wherein component (a) is enriched in a component (a) enantiomer of Formula I"compared to the racemic mixture When enantiomerically enriched, one enantiomer is present in greater amounts that the other and the extent of enrichment can be defined by an expression of enantiomer excess ("ee"), which is defined as 100 (2x-1) wherein x is the mole fraction of the dominant enantiomer in the enantiomer mixture (e. g. , an ee of 20% corresponds to a 60: 40 ratio of enantiomers).

The more active enantiomer with respect to the relative positions of Rl, R2, A and the rest of the molecule bonded through nitrogen corresponds to the configuration of the enantiomer that, when in a solution of CDC13, rotates plane polarized light in the (+) or dextro direction.

Preferably there is at least a 50% enantiomeric excess; more preferably at least a 75 % enantiomeric excess; still more preferably at least a 90% enantiomeric excess; and the most preferably at least a 94% enantiomeric excess of the more active isomer of Formula I. Of particular note are enantiomerically pure embodiments of the more active isomer of Formula I.

The salts of the compounds of the invention include acid-addition salts with inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric, 4-toluenesulfonic or valeric acids. The salts of the compounds of the invention also include those formed with organic bases (e. g. , pyridine, ammonia, or triethylamine) or inorganic t bases (e. g. , hydrides, hydroxides, or carbonates of sodium, potassium, lithium, calcium, magnesium or barium) when the compound contains an acidic group such as a carboxylic acid or phenol.

As noted above, X and either Y or Z are a linking chain 3 or 4 atoms in length attached to contiguous carbon atoms and are taken together with said carbon atoms to form a fused phenyl ring, a fused 5-or 6-membered nonaromatic carbocyclic or heterocyclic ring optionally including one or two ring members selected from the group consisting of C (=O), SO and S (0) 2, or a fused 5-or 6-membered heteroaromatic ring, each fused ring optionally substituted with one to three substituents independently selected from R7. The term "optionally substituted"in connection with these fused rings refers to rings which are unsubstituted or haye at, least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog. An example of a fused phenyl ring optionally substituted with one to three substituents independently selected from R7 is illustrated as K-38 in Exhibit 1. Examples of 5-or 6-membered heteroaromatic rings optionally substituted with 1 to 3 R7 include the rings K-1 through K-37 illustrated in Exhibit 1. Examples of 5-or 6-membered nonaromatic carbocyclic or heterocyclic rings optionally including one or two ring members selected from the group consisting of C (=O), SO and S (0) 2 optionally substituted with 1 to 3 R7 include the rings K-39 through K-53 illustrated in Exhibit 1. In these examples, the wavy lines indicate the attachment points of these fused rings to the rest of the molecule of Formula I and n is 0,1, 2 or 3. The attachment point illustrated at the upper right is the attachment point X and the attachment point illustrated at the lower right is the attachment point Y or the attachment point Z. R13 is a subset of R7 and is selected from H, C1-C4 alkyl or Cl-C4 haloalkyl. When Y or Z is not used as a ring fusion attachment point, that position is either unsubstituted (i. e. Y or Z is H) or is a group selected from R6.

Exhibit 1

Preferred fused rings are K-38, K-40 and K-2, each fused at the X and Z attachment points.

Preferred compounds for reasons of better activity and/or ease of synthesis are: Preferred 1. Compounds of Formula I above, an N-oxide or agriculturally suitable salts thereof, wherein X and either Y or Z and the carbon atoms to which they are attached form a fused 5-or 6-membered nonaromatic carbocyclic ring or a fused 5-or 6-membered nonaromatic heterocyclic ring, each fused ring optionally substituted with one to three substituents independently selected from R7.

Of note are compounds of Preferred 1 wherein each R5 is independently C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO2H, CONH2, N02, hydroxy, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, Cl-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, Cl-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, C2-C6 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl or C3-C6 trialkylsilyl.

Preferred 2. Compounds of Preferred 1 wherein one R5 is in the 3-position and a second Rs is in the 5-position and said two R5 groups are independently selected from the group consisting of C1-C6 alkyl, Cl-C6 haloalkyl, halogen, CN, Cl-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, Cl-C4 haloalkylthio, Cl-C4 haloalkylsulfinyl and Cl-C4 haloalkylsulfonyl.

Of note are compounds of Preferred 2 wherein each Rs is independently selected from the group consisting of Cl, Br, I, CH3, OCF3, OCHF2, OCH2CF3, OCF2CF3, OCF2CF2H, OCHFCF3, SCF3, SCHF2, SCH2CF3, SCF2CF3, SCF2CF2H, SCHFCFg, SOCF3, SOCHF2, SOCH2CF3, SOCF2CF3, SOCF2CF2H, SOCHFCF3, SO2CF3, SO2CHF2, S02CH2CF3, S02CF2CF3, SO2CF2CF2H and SO2CHFCF3.

Preferred 3. Compounds of Preferred 2 wherein the R5 in the 3-position is selected from halogen and the R5 in the 5-position is selected from the group consisting of halogen, C1-C6 haloalkyl, C1-C4 haloalkoxy, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl and C1-C4 haloalkylsulfonyl.

Preferred 4. Preferred are compounds of Preferred 3 wherein the R5 in the 3-position is selected from halogen and the R5 in the 5-position is selected from the group consisting of halogen, Cl-C6 haloalkoxy and C1-C6 haloalkyl.

Of note are compounds of Preferred 4 wherein the R5 in the 3-position is chloro and the R5 in the 5-position is trifluoromethyl.

Also of note are compounds of Preferred 4 wherein the R5 in the 3-position is chloro and the R5 in the 5-position is selected from halogen or C1-C6 haloalkoxy.

Preferred compositions of this invention include those of Preferred 1 through Preferred 4 wherein Rl is H and R2 is H or CH3. More prefened are compositions of Preferred 1 through Preferred 4 wherein RI is H and R2 is CH3.

Also preferred are compounds wherein each R6 is independently selected from halogen, C1-C6 alkyl, C1-C6 haloalkyl and Cl-C4 haloalkoxy, .

Specifically preferred is the compound 2, 4-dichloro-N [ [3-chloro-5- (trifluoromethyl)- 2-pyridinyl] methyl]-5, 6,7, 8-tetrahydro-3-quinolinecarboxamide.

Also specifically preferred are the compounds N [1-5-bromo-3-chloro-2-pyridinyl) ethyl]-3-chloro-4-isoquinolinecarboxamide ; 3-bromo-N-[1-(5-bromo-3-chloro-2-pyridinyl)ethyl]-4-isoquino linecarboxamide; and N-[1-(5-bromo-3-chloro-2-pyridinyl)ethyl]-3-fluoro-4-isoquin olinecarboxamide.

The compounds of Formula I can be prepared by one or more of the following methods and variations as described in Schemes 1-5. The definitions of A, B and Rl through R6 in the compounds of Formulas 1-4 below are as defined above. Compounds of Formula la, lb and lc are subsets of Formula 1. Compounds of Formulae Ia, Ib and Ic are subsets of the compounds of Formula I, and all substituents for Formulae la, Ib and Ic are as defined above for Formula I.

As shown in Scheme 1, the compounds of Formula la can be prepared by treating amine salts of Formula 1 with an appropriate acid chloride in an inert solvent with two molar equivalents of a base (e. g. triethylamine or potassium carbonate) present. Suitable solvents are selected from the group consisting of ethers such as tetrahydrofuran, dimethoxyethane, or diethyl ether ; hydrocarbons such as toluene or benzene; and halocarbons such as dichloromethane or chloroform.

Scheme 1 H 0 H !) base ! sH JQ base R1 R2 R1 R2 0 1 Ia

As depicted in Scheme 2, compounds of Formula la can be alternatively synthesized by reacting the amine salts of Formula 1 with an appropriate carboxylic acid in the presence of an organic dehydrating reagent such as 1, 3-dicyclohexylcarbodiimide (DCC) or 1- [3- (Dimethylamino) propyl] -3-ethylcarbodiimide hydrochloride (EDC). Suitable solvents are selected from the group consisting of ethers such as tetrahydrofuran, dimethoxyethane, or diethyl ether; hydrocarbons such as toluene or benzene; and halocarbons such as dichloromethane or chloroform. Some acids of Formula B-COOH are know compounds or can be prepared by literature procedures (Tetrahedron Letters 1973, 26, 2335 and Heterocycles 1989, 29 (4), 707-18) Scheme 2 H H ° DCC or EDC A NiHCl + 0 o A<B 1 in, 1 Ia. 1 la 1 Ia.

As shown in Scheme 3, the amine salts of Formula la, wherein A is 2-pyridyl bearing the indicated substituents and RI and R2 are hydrogen, can be prepared by reacting the commercially available imine ester 5 with a 2,3-dichloro-pyridine of Formula 4 in the presence of a strong base such as sodium hydride in a polar, aprotic solvent such as N, N-dimethylformamide followed by heating in acidic medium in a procedure analogous to those found in W099/42447. Compounds of Formula lb can be prepared by similar procedures in which the intermediate anion resulting from step 1 is treated with an alkylating agent R2-X such as methyl iodide prior to heating in an acidic medium. In the alkylating reagent R2-X, X is a suitable leaving group such as halogen (e. g. , Br, I), OS (O) 2CH3 (methanesulfonate), OS (O) 2CF3, OS (0) 2Ph-p-CH3 (p-toluenesulfonate), andthe like; methanesulfonate works well. Of note are compounds of la, lb and 4 wherein R5 is CFg. Also of note are compounds of la, lb and 4 wherein R5 is selected from halogen or C1-C6 haloalkoxy.

Scheme 3

As shown in Scheme 4, compounds of Formula lc (wherein A is a substituted 2- pyridinyl ring), bearing an aminomethyl group, can be synthesized from nitriles of Formula 2 (wherein A is a substituted 2-pyridinyl ring) by reduction of the nitrile using lithium aluminum hydride (LAH) in toluene.

Scheme 4

A is a substituted 2-pyridinyl ring As shown in Scheme 5, compounds of Formula lc (wherein A is a substituted 2- pyridinyl ring) can be alternatively synthesized by reacting compounds of Formula 3 with ammonia in a protic solvent such as methanol to'provide compounds of Formula lc.

Compounds of Formula lc can also be prepared by reacting compounds of Formula 3 with a potassium salt of phthalimide followed by reaction with either aminoethanol or hydrazine in an alcohol solvent to provide the desired aminomethyl intermediates of Formula lc.

Scheme 5

LG is Cl, Br,-OSO2Me,-OS02-p-Tol As shown in Scheme 6, carboxylic acids of Formula 8 can be prepared from an aminocarboxylate of Formula 6. Treatment of a compound of Formula 6 with dialkyl malonate followed by halogenation and hydrolysis provides an acid of Formula 8. Further experimental details for this method are described in Example 1.

Scheme 6 K K K R900C'COOR9 N l) halogenation I R8 2 base 2) hydroly5is. OH H X 0 6 R9/O \\O 8

R8 and R9 are independently C1-C4 alkyl; and X is halogen.

It is recognized that some reagents and reaction conditions described above for preparing compounds of Formula I may not be compatible with certain functionalities present in the intermediates. In these instances, the incorporation of protection/deprotection sequences or functional group interconversions into the synthesis will aid in obtaining the desired products. The use and choice of the protecting groups will be apparent to one skilled in chemical synthesis (see, for example, Greene, T. W.; Wuts, P. G. M. Protective Groups iii Organic Synthesis, 2nd ed.; Wiley: New York, 1991). One skilled in the art will recognize that, in some cases, after the introduction of a given reagent as it is depicted in any individual scheme, it may be necessary to perform additional routine synthetic steps not

described in detail to complete the synthesis of compounds of Formula I. One skilled in the art will also recognize that it may be necessary to perform a combination of the steps illustrated in the above schemes in an order other than that implied by the particular sequence presented to prepare the compounds of Formula I.

One skilled in the art will also recognize that compounds of Formula I and the intermediates described herein can be subjected to various electrophilic, nucleophilic, radical, organometallic, oxidation, and reduction reactions to add substituents or modify existing substituents.

Without further elaboration, it is believed that one skilled in the art using the preceding description can prepare compounds comprising component (a) of the present invention to its fullest extent. The following Example is, therefore, to be construed as merely illustrative, and not limiting of the disclosure in any way whatsoever. Percentages are by weight except for chromatographic solvent mixtures or where otherwise indicated. Parts and percentages for chromatographic solvent mixtures are by volume unless otherwise indicated. 1H NMR spectra are reported in ppm downfield from tetramethylsilane; s is singlet, d is doublet, t is triplet, q is quartet, m is multiplet, dd is doublet of doublets, dt is doublet of triplets, br s is broad singlet.

Example 1 Preparation of 2, 4-Dichloro-N [ (3-chloro-5- (trifluorometh, y_ll-2-pridin] meth]-5, 6, 7, 8- tetrahydro-3-quinolinecarboxamide Step A: Preparation of Ethyl 1 4, 5, 6, 7, 8-hexgbydro-2--hydroxy-4-oxo-3- quinolinecarboxylate A solution of ethyl 2-amino-l-cyclohexene-l-carboxylate (5.0 g), diethyl malonate (4.7 mL) and sodium ethoxide (2.68 M in ethanol, 12 mL) in ethanol (6 mL) was heated to reflux overnight. The reaction mixture was cooled to room temperature, poured into water and acidified with concentrated HC1 to precipitate a tan solid. The solid was filtered, washed with ethyl acetate and dried to yield 630 mg of the title compound. <BR> <BR> <P>Step B : Preparation of Ethyl 2, 4-dichloro-5. 6. 7, 8-tetrahydro-3-quinolinecarboxylate A solution of ethyl 1, 4,5, 6,7, 8-hexahydro-2-hydroxy-4-oxo-3-quinolinecarboxylate (i. e. the product of Step A) (630 mg) in phosphorus oxychloride (10 mL) was refluxed overnight. The reaction mixture was cooled to room temperature and concentrated under reduced pressure. The residue was partitioned between ethyl acetate and water. The organic extracts were dried over magnesium sulfate and concentrated under reduced pressure. The crude product was purified by chromatography oh silica gel to give the title compound (580 mg).

Step C: Preparation of 2 ! 4-Dichloro-5 ! 678-tetrahydro-3-quinolinecarboxaldehvde To a solution of ethyl 2,4-dichloro-5, 6,7, 8-tetrahydro-3-quinolinecarboxylate (i. e. the product from Step B) (450 mg) in 13 mL of dichloromethane at 0 °C was added diisobutylaluminum hydride (1.0 M in dichloromethane, 5 mL). After stirring at 0 °C for 5 hours following by warming up to room temperature overnight, the reaction mixture was added methanol (10 mL) and stirred for additional 30 minutes. The resulting mixture was extracted with ethyl acetate. The extracts were dried over magnesium sulfate and concentrated under reduced pressure to give 346 mg of the title compound as an oil.

Step D: Preparation of2. 4-Dichloro-5. 6. 7. 8-tetrahydro-3-quinolinecarboxylic acid A mixture of 2, 4-dichloro-5,6, 7,8-tetrahydro-3-quinolinecarboxaldehyde (i. e. the product from Step C) (130 mg), sodium chlorite (78 mg) and sulfamic acid (71 mg) in tetrahydrofuran (2 mL) and water (5 mL) was stirred at room temperature for 3 hours. The mixture was then adjusted to a pH = 11 by adding 1N aqueous NaOH followed by extraction with ethyl acetate. The aqueous layer was then acidified with concentrated HC1 to bring the solution to a pH = 2 and extracted with ethyl acetate. The organic extracts were dried over magnesium sulfate and concentrated under reduced pressure to give 116 mg of the title compound.

Step E Preparation of 2, 4-Dichloro-N [j3-chloro-5- (trifluoromethyl)-2- pyridinyl] methyl]-5, 6y7y8-tetrahydro-3-quinolinecarboxamide A mixture of 2, 4-dichloro-5,6, 7, 8-tetrahydro-3-quinolinecarboxylic acid (116 mg) (i. e. the product from Step D), oxalyl chloride (358 mg) and 1 drop of N, N dim. ethylformamide in 5 mL of dichloromethane was stirred at room temperature for 3 hours. The reaction mixture was then concentrated under reduced pressure to give 124mg of the corresponding acid chloride intermediate. The crude acid chloride was dissolved in 1 mL of dichloromethane and added to a solution of triethylamine (0.073 mL) and 2-aminomethyl-3-chloro-5- trifluoromethylpyridine hydrochloride (109 mg) (prepared as described in W099/42447) in dichloromethane (19 mL) at room temperature. After stirring at room temperature overnight, the reaction mixture was washed with 1N aqueous HC1. The organic phase was dried over magnesium sulfate and concentrated under reduced pressure to give an oil. The oil was chromatographed on silica gel using 1: 1 hexanes: ethyl acetate as eluent to give 141 mg of the title compound as a yellow solid melting at 48-50 °C.

By the procedures described herein together with methods known in the art, the following compounds of Tables 1-2 can be prepared. The following abbreviations are used in the Tables which follow: t is tertiary, s is secondary, n is normal, i is iso, c is cyclo, Me is methyl, Et is ethyl, Pr is propyl, i-Pr is isopropyl, Bu is butyl, Ph is phenyl, OMe is methoxy, OEt is ethoxy, SMe is methylthio, SEt is ethylthio, CN is cyano, NO2 is nitro, TMS is trimethylsilyl, S (O) Me is methylsulfinyl, and S (O) 2Me is methylsulfonyl.

Table 1 K-1 Rl R2 (R5)m R6a R6b R7 R1 R2 (R5)m R6a R6b R7 H H 3-Cl-5-Br Cl Cl H H H 3-Cl-5-Br C1 H H H H 3-C1-5-Cl Cl Cl H H H 3-C1-5-C1 C1 H H H H 3-CI-5-I Cl Cl H H H 3-Cl-5-I Cl H H H H 3-Cl-5-OCHF2 Cl Cl H H H 3-Cl-5-OCHF2 Cl H H H H 3-Cl-5-OCH2CF3 Cl Cl H H H 3-Cl-5-OCH2CF3 Cl H H H H 3-C1-5-CF3 Cl Cl H H H 3-C1-5-CF3 Cl H H H H 3-Br-5-Br Cl Cl H H H 3-Br-5-Br Cl H H H H 3-Br-5-Cl Cl Cl H H H 3-Br-5-Cl Cl H H H H 3-Br-5-I Cl Cl H H H 3-Br-5-I Cl H H H H 3-Br-5-OCHF2 Cl Cl H H H 3-Br-5-OCHF2 Cl H H H H 3-Br-5-OCH2CF3 Cl Cl H H H 3-Br-5-OCH2CF3 Cl H H H H 3-Br-5-CF3 Cl Cl H H H 3-Br-5-CF3 Cl H H H CH3 3-Cl-5-Br Cl Cl H H CH3 3-Cl-5-Br Cl H H H CH3 3-Cl-5-Cl Cl Cl H H CH3 3-Cl-5-Cl Cl H H H CH3 3-C1-5-I Cl Cl H H CH3 3-Cl-5-I Cl H H H CH3 3-C1-5-OCHF2 Cl Cl H H CH3 3-Cl-5-OCHF2 Cl H H H CH3 3-C1-5-OCH2CF3 Cl Cl H H CH3 3-C1-5-OCH2CF3 Cl H H H CH3 3-Cl-5-CF3 Cl Cl H H CH3 3-Cl-5-CF3 Cl H H H CH3 3-Br-5-Br Cl Cl H H CH3 3-Br-5-Br Cl H H H CH3 3-Br-5-Cl Cl Cl H H CH3 3-Br-5-Cl Cl H H H CH3 3-Br-5-I Cl Cl H H CH3 3-Br-5-I Cl H H H CH3 3-Br-5-OCHF2 Cl Cl H H CH3 3-Br-5-OCHF2 Cl H H H CH3 3-Br-5-OCH2CF3 Cl Cl H H CH3 3-Br-5-OCH2CF3 Cl H H H CH3 3-Br-5-CF3 Cl Cl-H H CH3 3-Br-5-CF3 Cl H H K-2 R1 R2 (R5)m R6a R6b R7 R1 R2 (R5)m R6a R6b R7 H H 3-Cl-5-Br Cl Cl H H H 3-Cl-5-Br Cl H H (R5)m R6a R6b R7 R1 R2 (R5)m R6a R6b R7 H H 3-Cl-5-Cl Cl Cl H H H 3-Cl-5-Cl C1 H H H H 3-Cl-5-I Cl Cl H H H 3-Cl-5-I Cl H H H H 3-C1-5-OCHF2 Cl Cl H H H 3-C1-5-OCHF2 Cl H H H H 3-Cl-5-OCH2CF3 Cl Cl H H H 3-Cl-5-OCH2CF3 Cl H H H H 3-C1-5-CF3 Cl Cl H H H 3-C1-5-CF3 Cl H H H H 3-Br-5-Br Cl Cl H H H 3-Br-5-Br Cl H H H H 3-Br-5-Cl CI Cl H H H 3-Br-5-Cl C1 H H H H 3-Br-5-I Cl Cl H H H 3-Br-5-I Cl H H H H 3-Br-5-OCHF2 Cl Cl H H H 3-Br-5-OCHF2 Cl H H H H 3-Br-5-OCH2CF3 Cl Cl H H H 3-Br-5-OCH2CF3 Cl H H H H 3-Br-5-CF3 Cl Cl H H H 3-Br-5-CF3 Cl H H H CH3 3-Cl-5-Br Cl Cl H H CH3 3-Cl-5-Br Cl H H H CH3 3-Cl-5-Cl Cl Cl H H CH3 3-Cl-5-Cl Cl H H H CH3 3-Cl-5-I Cl Cl H H CH3 3-Cl-5-I Cl H H H CH3 3-Cl-5-OCHF2 Cl Cl H H CH3 3-C1-5-OCHF2 Cl H H H CH3 3-C1-5-OCH2CF3 Cl Cl H H CH3 3-Cl-5-OCH2CF3 Cl H H H CH3 3-C1-5-CF3 Cl Cl H H CH3 3-C1-5-CF3 Cl H H H CH3 3-Br-5-Br Cl Cl H H CH3 3-Br-5-Br Cl H H H CH3 3-Br-5-Cl Cl Cl H H CH3 3-Br-5-Cl Cl H H H CH3 3-Br-5-I CI Cl H H CH3 3-Br-5-I Cl H H H CH3 3-Br-5-OCHF2 Cl Cl H H CH3 3-Br-5-OCHF2 Cl H H H CH3 3-Br-5-OCH2CF3 Cl Cl H H CH3 3-Br-5-OCH2CF3 Cl H H H CH3 3-Br-5-CF3 Cl Cl H H CH3 3-Br-5-CF3 Cl H H K-3 Rl R2 (R5)m R6a R6b R7 R1 R2 (R5)m R6a R6b R7 H H 3-Cl-5-Br Cl Cl H H H 3-Cl-5-Br Cl H H H H 3-C1-5-C1 Cl Cl H H H 3-Cl-5-Cl Cl H H H H 3-Cl-5-I Cl Cl H H H 3-Cl-5-I Cl H H H H 3-Cl-5-OCHF2 Cl Cl H H H 3-Cl-5-OCHF2 Cl H H H H 3-Cl-5-OCH2CF3 Cl Cl H H H 3-C1-5-OCH2CF3 Cl H H H H 3-Cl-5-CF3 Cl Cl H H H 3-C1-5-CF3 Cl H H H H 3-Br-5-Br Cl Cl H H H 3-Br-5-Br Cl H H H H 3-Br-5-Cl Cl Cl H H H 3-Br-5-Cl Cl H H H H 3-Br-5-I Cl Cl H H H 3-Br-5-I Cl H H H H 3-Br-5-OCHF2 Cl Cl H H H 3-Br-5-OCHF2 Cl H H H H 3-Br-5-OCH2CF3 Cl Cl H H H 3-Br-5-OCH2CF3 Cl H H R2 (R5)m R6a R6b R7 R1 R2 (R5)m R6a R6b R7 H H 3-Br-5-CF3 Cl Cl H H H 3-Br-5-CF3 Cl H H H CH3 3-Cl-5-Br Cl Cl H H CH3 3-Cl-5-Br Cl H H H CH3 3-Cl-5-Cl Cl Cl H H CH3 3-Cl-5-Cl Cl H H H CH3 3-Cl-5-I Cl Cl H H CH3 3-Cl-5-I Cl H H H CH3 3-C1-5-OCHF2 Cl Cl H H CH3 3-C1-5-OCHF2 Cl H H H CH3 3-C1-5-OCH2CF3 Cl Cl H H CH3 3-Cl-5-OCH2CF3 Cl H H H CH3 3-C1-5-CF3 Cl Cl H H CH3 3-Cl-5-CF3 Cl H-H H CH3 3-Br-5-Br Cl Cl H H CH3 3-Br-5-Br Cl H H H CH3 3-Br-5-Cl Cl Cl H H CH3 3-Br-5-Cl Cl H H H CH3 3-Br-5-I Cl Cl H H CH3 3-Br-5-I Cl H H H CH3 3-Br-5-OCHF2 Cl Cl H H CH3 3-Br-5-OCHF2 Cl H H H CH3 3-Br-5-OCH2CF3 Cl Cl H H CH3 3-Br-5-OCH2CF3 Cl H H H CH3 3-Br-5-CF3 Cl Cl H H CH3 3-Br-5-CF3 Cl H H K-4 R1 R2 (R5)m R6a R6b R7 R1 R2 (R5)m R6a R6b R7 H H 3-Cl-5-Br Cl Cl H H H 3-Cl-5-Br Cl H H H H 3-C1-5-Cl Cl Cl H H H 3-Cl-5-Cl Cl H H H H 3-Cl-5-I Cl Cl H H H 3-C1-5-I Cl H H H H 3-Cl-5-OCHF2 Cl Cl H H H 3-Cl-5-OCHF2 Cl H H H H 3-Cl-5-OCH2CF3 Cl Cl H H H 3-Cl-5-OCH2CF3 Cl H H H H 3-Cl-5-CF3 Cl Cl H H H 3-Cl-5-CF3 Cl H H H H 3-Br-5-Br Cl Cl H H H 3-Br-5-Br Cl H H H H 3-Br-5-Cl Cl Cl H H H 3-Br-5-Cl Cl H H H H 3-Br-5-I Cl Cl H H H 3-Br-5-I Cl H H H H 3-Br-5-OCHF2 Cl Cl H H H 3-Br-5-OCHF2 Cl H H H H 3-Br-5-OCH2CF3 Cl Cl H H H 3-Br-5-OCH2CF3 Cl H H H H 3-Br-5-CF3 Cl Cl H H H 3-Br-5-CF3 Cl H H H CH3 3-Cl-5-Br Cl Cl H H CH3 3-Cl-5-Br Cl H H H CH3 3-Cl-5-Cl Cl Cl H H CH3 3-Cl-5-Cl Cl H H H CH3 3-Cl-5-I Cl Cl H H CH3 3-Cl-5-I Cl H H H CH3 3-Cl-5-OCHF2 Cl Cl H H CH3 3-C1-5-OCHF2 Cl H H H CH3 3-Cl-5-OCH2CF3 Cl Cl H H CH3 3-Cl-5-OCH2CF3 Cl H H H CH3. 3-Cl-5-CF3 Cl Cl H H CH3 3-Cl-5-CF3 Cl H H H CH3 3-Br-5-Br Cl Cl H H CH3 3-Br-5-Br Cl H H H CH3 3-Br-5-Cl Cl Cl H H CH3 3-Br-5-Cl Cl H H H CH3 3-Br-5-I Cl Cl H H CH3 3-Br-5-I Cl H H R1 R2 (R5)m R6a R6b R7 R1 R2 (R5)m R6a R6b R7 H CH3 3-Br-5-OCHF2 Cl Cl H H CH3 3-Br-5-OCHF2 Cl H H H CH3 3-Br-5-OCH2CF3 Cl Cl H H CH3 3-Br-5-OCH2CF3 Cl H H H CH3 3-Br-5-CF3 Cl Cl H H CH3 3-Br-5-CF3 Cl H H K-38 Rl R2 (R5)m R6a R6b R7 R1 R2 (R5)m R6a R6b R7 H H 3-Cl-5-Br Cl Cl H H H 3-Cl-5-Br Cl H H H H 3-Cl-5-Cl Cl CI H H H 3-Cl-5-Cl Cl H H H H 3-Cl-5-I Cl Cl H H H 3-Cl-5-I Cl H H H H 3-C1-5-OCHF2 Cl Cl H H H 3-C1-5-OCHF2 Cl H H H H 3-C1-5-OCH2CF3 Cl Cl H H H 3-Cl-5-OCH2CF3 Cl H H H H 3-Cl-5-CF3 Cl Cl H H H 3-Cl-5-CF3 Cl H H H H 3-Br-5-Br Cl Cl H H H 3-Br-5-Br C1 H H H H 3-Br-5-Cl Cl Cl H H H 3-Br-5-Cl Cl H H H H 3-Br-5-I Cl Cl H H H 3-Br-5-I Cl H H H H 3-Br-5-OCHF2 Cl Cl H H H 3-Br-5-OCHF2 Cl H H H H 3-Br-5-OCH2CF3 Cl Cl H H H 3-Br-5-OCH2CF3 Cl H H H H 3-Br-5-CF3 Cl Cl H H H 3-Br-5-CF3 Cl H H H CH3 3-Cl-5-Br Cl Cl H H CH3 3-Cl-5-Br ci H H H CH3 3-Cl-5-Cl Cl Cl H H CH3 3-Cl-5-Cl Cl H H H CH3 3-Cl-5-I Cl Cl H H CH3 3-Cl-5-I Cl H H H CH3 3-C1-5-OCHF2 Cl Cl H H CH3 3-C1-5-OCHF2 Cl H H H CH3 3-C1-5-OCH2CF3 Cl Cl H H CH3 3-Cl-5-OCH2CF3 Cl H H H CH3 3-C1-5-CF3 Cl Cl H, H CH3 3-Cl-5-CF3 Cl H H H CH3 3-Br-5-Br Cl Cl H H CH3 3-Br-5-Br Cl H H H CH3 3-Br-5-Cl Cl Cl H H CH3 3-Br-5-Cl Cl H H H CH3 3-Br-5-I Cl Cl H H CH3 3-Br-5-I Cl H H H CH3 3-Br-5-OCHF2 Cl Cl H H CH3 3-Br-5-OCHF2 Cl H H H CH3 3-Br-5-OCH2CF3 Cl Cl H H CH3 3-Br-5-OCH2CF3 Cl H H H CH3 3-Br-5-CF3 Cl Cl H H CH3 3-Br-5-CF3 Cl H H K-40 (R5)m R6a R6b R7 R1 R2 (R5)m R6a R6b R7 H H 3-Cl-5-Br Cl Cl H H H 3-Cl-5-Br Cl H H H H 3-C1-5-C1 Cl Cl H H H 3-Cl-5-Cl Cl H H H H 3-Cl-5-I Cl Cl H H H 3-Cl-5-I Cl H H H H 3-C1-5-OCHF2 Cl Cl H H H 3-C1-5-OCHF2 Cl H H R1 R2 (R5)m R6a R6b R7 R1 R2 (R5)m R6a R6b R7 H H 3-Cl-5-OCH2CF3 Cl Cl H H H 3-Cl-5-OCH2CF3 Cl H H H H 3-Cl-5-CF3 Cl Cl H H H 3-C1-5-CF3 Cl H H H H 3-Br-5-Br Cl Cl H H H 3-Br-5-Br Cl H H H H 3-Br-5-Cl Cl Cl H H H 3-Br-5-Cl Cl H H H H 3-Br-5-I Cl Cl H H H 3-Br-5-I Cl H H H H 3-Br-5-OCHF2 Cl Cl H H H 3-Br-5-OCHF2 Cl H H H H 3-Br-5-OCH2CF3 Cl Cl H H H 3-Br-5-OCH2CF3 Cl H H H H 3-Br-5-CFB Cl Cl H H H 3-Br-5-CF3 Cl H H H CH3 3-Cl-5-Br Cl Cl H H CH3 3-Cl-5-Br Cl H H H CH3 3-Cl-5-Cl Cl Cl H H CH3 3-Cl-5-Cl Cl H H H CH3 3-Cl-5-I Cl Cl H H CH3 3-Cl-5-I Cl H H H CH3 3-C1-5-OCHF2 Cl Cl H H CH3 3-Cl-5-OCHF2 Cl H H H CH3 3-C1-5-OCH2CF3 Cl Cl H H CH3 3-Cl-5-OCH2CF3 Cl H H H CH3 3-Cl-5-CF3 Cl Cl H H CH3 3-C1-5-CF3 Cl H H H CH3 3-Br-5-Br Cl Cl H H CH3 3-Br-5-Br Cl H H H CH3 3-Br-5-Cl Cl Cl H H CH3 3-Br-5-Cl Cl H H H CH3 3-Br-5-I Cl Cl H H CH3 3-Br-5-I Cl H H H CH3 3-Br-5-OCHF2 Cl Cl H H CH3 3-Br-5-OCHF2 ci H H H CH3 3-Br5-OCH2CF3 Cl Cl H H CH3 3-Br-5-OCH2CF3 Cl H H H CH3 3-Br-5-CF3 Cl Cl H H CH3 3-Br-5-CF3 Cl H H Table 2 K-1 RI R2 (R5)m R6a R6b R7 H H 3-Cl-5-Br Cl Cl H H H 3-Cl-5-Cl C1 C1 H H H 3-Cl-5-I Cl Cl H H H 3-C1-5-OCHF2 Cl Cl H H H 3-Cl-5-OCHF2CF3 Cl Cl H H H 3-C1-5-CF3 Cl Cl R1 R2 (R5)m R6a R6b R7 H H 3-Br-5-Br Cl Cl H H H 3-Br-5-Cl Cl C1 H H H 3-Br-5-I Cl Cl H H H 3-Br-5-OCHF2 Cl Cl H H H 3-Br-5-OCH2CF3 Cl Cl H H H 3-Br-5-CFg Cl Cl H H CH 3-Cl-5-Br Cl Cl H H CH3 3-Cl-5-Cl Cl Cl H H CH3 3-Cl-5-I Cl Cl H H CH3 3-C1-5-OCHF2 Cl Cl H H CH3 3-Cl-5-OCH2CF3 Cl Cl H H CH3 3-Cl-5-CF3 Cl Cl H H CH3 3-Br-5-Br Cl Cl H H CH3 3-Br-5-Cl Cl Cl H H CH3 3-Br-5-I Cl Cl H H CH3 3-Br-5-OCHF2 Cl Cl H H CH3 3-Br-5-OCH2CF3 CI Cl H H CH3 3-Br-5-CF3 Cl Cl H K-2 RI R2 (R5)m R6a R6b R7 H H 3-Cl-5-Br C1 Cl H H H 3-CI-5-C1 C1 C1 H H H 3-Cl-5-I C1 Cl H H H 3-C1-5-OCHF2 Cl Cl H H H 3-C1-5-OCH2CF3 Cl Cl H H H 3-Cl-5-CFg Cl Cl H H H 3-Br-5-Br Cl C1 H H H 3-Br-5-Cl C1 C1 H H H 3-Br-5-I Cl Cl H H H 3-Br-5-OCHF2 Cl Cl H H H 3-Br-5-OCH2CF3 Cl Cl H H H 3-Br-5-CF3 Cl Cl H H CH3 3-Cl-5-Br Cl Cl H H CH3 3-C1-5-Cl Cl Cl H H CH3 3-Cl-5-I Cl Cl H H CH3 3-C1-5-OCHF2 Cl Cl H RI R2 (R5)m R6a R6b R7 H CH3 3-Cl-5-OCH2CF3 Cl Cl H H CH3 3-C1-5-CF3 Cl Cl H H CH3 3-Br-5-Br Cl Cl H H CH3 3-Br-5-Cl Cl Cl H H CH3 3-Br-5-I Cl Cl H H CH3 3-Br-5-OCHF2 Cl Cl H H CH3 3-Br-5-OCH2CF3 Cl Cl H H CH 3-Br-5-CF3 CI Cl H K-3 R1 R2 (R5)m R6a R6b R7 H H 3-Cl-5-Br Cl Cl H H H 3-Cl-5-Cl Cl Cl H H H 3-Cl-5-I Cl Cl H H H 3-C1-5-OCHF2 Cl Cl H H H 3-Cl-5-OCH2CF3 Cl Cl H H H 3-C1-5-CF3 Cl Cl H H H 3-Br-5-Br Cl Cl H H H 3-Br-5-Cl Cl Cl H H H 3-Br-5-I Cl Cl H H H 3-Br-5-OCHF2 Cl Cl H H H 3-Br-5-OCH2CF3 Cl Cl H H H 3-Br-5-CF3 Cl Cl H H CH3 3-Cl-5-Br Cl Cl H H CH3 3-Cl-5-Cl Cl Cl H H CH3 3-Cl-5-I Cl Cl H H CH3 3-C1-5-OCHF2 Cl Cl H H CH3 3-Cl-5-OCH2CF3 Cl Cl H H CH3 3-Cl-5-CF3 Cl Cl H H CH3 3-Br-5-Br Cl Cl H H CH3 3-Br-5-Cl Cl Cl H H CH3 3-Br-5-I Cl Cl H H CH3 3-Br-5-OCHF2 Cl Cl H H CH3 3-Br-5-OCH2CF3 Cl Cl H H CH3 3-Br-5-CF3 Cl Cl H K-4 R1 R2 (R5)m R6a R6b R7 H H 3-C1-5-Br C1 Cl H H H 3-C1-5-C1 Cl Cl H H H 3-Cl-5-I Cl Cl H H H 3-C1-5-OCHF2 Cl Cl H H H 3-Cl-5-OCH2CF3 Cl Cl H H H 3-C1-5-CF3 Cl Cl H H H 3-Br-5-Br Cl Cl H H H 3-Br-5-C1 C1 Cl H H H 3-Br-5-I Cl Cl H H H 3-Br-5-OCHF2 Cl Cl H H H 3-Br-5-OCH2CF3 Cl Cl H H H 3-Br-5-CF3 Cl Cl H H CH3 3-CI-5-Br Cl Cl H H CH3 3-Cl-5-Cl Cl Cl H H CH3 3-Cl-5-I Cl Cl H H CH3 3-C1-5-OCHF2 Cl Cl H H CH3 3-Cl-5-OCH2CF3 Cl Cl H H CH3 3-C1-5-CF3 Cl Cl H H CH3 3-Br-5-Br Cl Cl H H CH3 3-Br-5-Cl Cl Cl H H CH3 3-Br-5-I Cl Cl H H CH3 3-Br-5-OCHF2 Cl Cl H H CH3 3-Br-5-OCH2CF3 Cl Cl H H CH3 3-Br-5-CF3 Cl Cl H K-38 R1 R2 (R5)m R6a R6b R7 H H 3-C1-5-Br C1 C1 H H H 3-Cl-5-Cl C1 C1 H H H 3-C1-5-I Cl Cl H H H 3-C1-5-OCHF2 Cl Cl H H 3-Cl-5-OCH2CF3 Cl Cl H H H 3-Cl-5-CF3 Cl Cl H H H 3-Br-5-Br Cl Cl H H 3-Br-5-C1 C1 C1 H H 3-Br-5-I Cl Cl H H 3-Br-5-OCHFz Cl Cl H Rl R2 (R5)m R6a R6b R7 H H 3-Br-5-OCH2CF3 Cl Cl H H H 3-Br-5-CF3 Cl Cl H H CH3 3-Cl-5-Br Cl Cl H H CH3 3-C1-5-C1 Cl Cl H H CH3 3-Cl-5-I Cl Cl H H CH3 3-Cl-5-OCHF2 Cl Cl H H CH3 3-Cl-5-OCH2CF3 Cl Cl H H CH3 3-Cl-5-CF3 Cl Cl H H CH3 3-Br-5-Br Cl Cl H H CH3 3-Br-5-Cl Cl Cl H H CH3 3-Br-5-I Cl Cl H H CH3 3-Br-5-OCHF2 Cl Cl H H CH3 3-Br-5-OCH2CF3 Cl Cl H H CH3 3-Br-5-CF3 Cl Cl H K-40 RI R2 (R5)m R6a R6b R7 H H 3-Cl-5-Br Cl ci H H H 3-Cl-5-Cl Cl Cl H H H 3-Cl-5-I Cl Cl H H H 3-C1-5-OCHF2 Cl Cl H H H 3-Cl-5-OCH2CF3 Cl Cl H H H 3-Cl-5-CF3 Cl Cl H H H 3-Br-5-Br Cl Cl H H H 3-Br-5-Cl Cl Cl H H H 3-Br-5-I Cl Cl H H H 3-Br-5-OCHF2 Cl Cl H H H 3-Br-5-OCH2CF3 Cl Cl H H H 3-Br-5-CF3 Cl Cl H H CH3 3-Cl-5-Br Cl Cl H H CH3 3-Cl-5-Cl Cl Cl H H CH3 3-Cl-5-I Cl Cl H H CH3 3-C1-5-OCHF2 Cl Cl H H CH3 3-C1-5-OCH2CF3 Cl Cl H H CH3 3-C1-5-CF3 Cl Cl H H CH3 3-Br-5-Br Cl Cl H H CH3 3-Br-5-Cl Cl Cl H

R1 R2 %) m R6a R6b R7 H CH3 3-Br-5-I Cl Cl H H CH3 3-Br-5-OCHF2 Cl Cl H H CH3 3-Br-5-OCH2CF3 Cl Cl H H CH3 3-Br-5-CF3 Cl Cl H This invention also relates to fungicidal compositions comprising fungicidally effective amounts of a composition of the compounds of the invention and at least one additional component selected from the group consisting of surfactants, solid diluents, liquid diluents and other fungicides. Included are fungicidal compositions comprising a fungicidally effective amount of at least one compound of Formula I and at least one other fungicide.

Of note are compositions comprising (a) at least one compound of Formula I ; and (b) at least one compound selected from the group consisting of (bl) alkylenebis (dithiocarbamate) fungicides; (b2) compounds acting at the bc1 complex of the fungal mitochondrial respiratory electron transfer site; (b3) cymoxanil ; (b4) compounds acting at the demethylase enzyme of the sterol biosynthesis pathway; (b5) morpholine and piperidine compounds that act on the sterol biosynthesis pathway; (b6) phenylamide fungicides; (b7) pyrimidinone fungicides; (b8) phthalimides; and (b9) fosetyl-aluminum.

The weight ratios of component (b) to component (a) typically is from 100: 1 to 1: 100, preferably is from 30 : 1 to 1 : 30, and more preferably is from 10 : 1 to 1: 10. Of note are compositions wherein the weight ratio of component (b) to component (a) is from 10: 1 to 1: 1. Included are compositions wherein the weight ratio of component (b) to component (a) is from 9: 1 to 4.5 : 1.

The bel Complex Fungicides (component (b2) Strobilurin fungicides such as azoxystrobin, kresoxim-methyl, metominostrobin/fenominostrobin (SSF-126), picoxystrobin, pyraclostrobin and trifloxystrobin are known to have a fungicidal mode of action which inhibits the bcl complex in the mitochondrial respiration chain (l. szgew. Chem. Int. Ed., 1999, 38, 1328- 1349). Methyl (E)-2-[[6-(2-cyanophenoxy)-4-pyrimidinyl] oxy]-oc- (methoxyimino) benzeneacetate (also known as azoxystrobin) is described as a bel complex inhibitor in Biochemical Society Transactions 1993,22, 68S. Methyl (E)-a- (methoxyimino)-2- [ (2-methylphenoxy) methyl] benzeneacetate (also known as kresoxim-

methyl) is described as a bcl complex inhibitor in Biochemical Society Transactioras 1993, 22,64S. (E)-2-[(2, 5-Dimethylphenoxy) methyl]-a-(methoxyimino)-N- methylbenzeneacetamide is described as a bc] complex inhibitor in Biochemistry and Cell Biology 1995, 85 (3), 306-311. Other compounds that inhibit the bc1 complex in the mitochondrial respiration chain include famoxadone and fenamidone.

The bel complex is sometimes referred to by other names in the biochemical literature, including complex III of the electron transfer chain, and ubihydroquinone : cytochrome c oxidoreductase. It is uniquely identified by the Enzyme Commission number EC1.10. 2.2.

The bcl complex is described in, for example, J. Biol. Chem. 1989, 264, 14543-38 ; Methods Enzymol. 1986, 126, 253-71; and references cited therein.

The Sterol Biosynthesis Inhibitor'Fungici es (component (b4) or (b5)) The class of sterol biosynthesis inhibitors includes DMI and non-DMI compounds, that control fungi by inhibiting enzymes in the sterol biosynthesis pathway. DMI fungicides have a common site of action within the fungal sterol biosynthesis pathway; that is, an inhibition of demethylation at position 14 of lanosterol or 24-methylene dihydrolanosterol, which are precursors to sterols in fungi. Compounds acting at this site are often referred to as demethylase inhibitors, DMI fungicides, or DMIs. The demethylase enzyme is sometimes referred to by other names in the biochemical literature, including cytochrome P-450 (14DM). The demethylase enzyme is described in, for example, J. BioL Cheiiz. 1992, 267, 13175-79 and references cited therein. DMI fungicides fall into several classes: azoles (including triazoles and imidazoles), pyrimidines, piperazines and pyridines. The triazoles includes bromuconazole, cyproconazole, difenoconazole, diniconazole, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, ipconazole, metconazole, penconazolè, propiconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole and uniconazole. The imidazoles include clotrimazole, econazole, imazalil, isoconazole, miconazole and prochloraz. The pyrimidines include fenarimol, nuarimol and triarimol. The piperazines include triforine. The pyridines include buthiobate and pyrifenox. Biochemical investigations have shown that all of the above mentioned fungicides are DMI fungicides as described by K. H. Kuck, et al. in Modei-7i Selective Fu7lgicides-Properties, Applicatio7ls a7-d A6echanisms of Action, Lyr, H. , Ed.; Gustav Fischer Verlag: New York, 1995,205-258.

The DMI fungicides have been grouped together to distinguish them from other sterol biosynthesis inhibitors, such as, the morpholine and piperidine fungicides. The morpholines and piperidines are also sterol biosynthesis inhibitors but have been shown to inhibit later steps in the sterol biosynthesis pathway. The morpholines include aldimorph, dodemorph, fenpropimorph, tridemorph and trimorphamide. The piperidines include fenpropidin.

Biochemical investigations have shown that all of the above mentioned morpholine and piperidine fungicides are sterol biosynthesis inhibitor fungicides as described by K. H. Kuck, et al. in Modern Selective Fungicides-Properties, Applications and Mechanisms of Action, Lyr, H. , Ed.; Gustav Fischer Verlag : New York, 1995,185-204.

Pyrimidinone Fungicides (component (b7)) Pyrimidinone fungicides include compounds of Formula II

wherein G is a fused phenyl, thiophene or pyridine ring; Rl is C1-C6 alkyl ; R2 is C1-C6 alkyl or C1-C6 alkoxy ; R3 is halogen; and R4 is hydrogen or halogen.

Pyrimidinone fungicides are described in International Patent Application W094/26722, U. S. Patent No. 6,066, 638, U. S. Patent No. 6,245, 770, U. S. Patent No.

6,262, 058 and U. S. Patent No. 6,277, 858.

Of note are pyrimidinone fungicides selected from the group: 6-bromo-3-propyl-2-propyloxy-4 (3H)-quinazolinone, 6,8-diiodo-3-propyl-2-propyloxy-4 (3$-quinazolinone, 6-iodo-3-propyl-2-propyloxy-4 (3h7)-quinazolinone, 6-chloro-2-propoxy-3-propylthieno [2, 3-dlpyrimidin-4 (3H)-one, 6-bromo-2-propoxy-3-propylthieno [2, 3-d] pyrimidin-4 (3H)-one, 7-bromo-2-propoxy-3-propylthieno [3, 2-d]pyrimidin-4(3H)-one, 6-bromo-2-propoxy-3-propylpyrido[2,3-d]pyrimidin-4(3H)-one, 6, 7-dibromo-2-propoxy-3-propylthieno [3, 2-d] pyrimidin-4 (3H)-one, and 3- (cyclopropylmethyl)-6-iodo-2- (propylthio) pyrido [2, 3-d]pyrimidin-4(3H)-one.

Table 8 Examples of component (b) (bl) Alkylenebis (dithiocarbamate) s such as mancozeb, maneb, propineb and zineb (b3) Cymoxanil (b6) Phenylamides such as metalaxyl, benalaxyl and oxadixyl (b8) Phthalimids such as folpet or captan (b9) Fosetyl-aluminum Preferred 5. Preferred compositions comprise a compound of component (a) mixed with cymoxanil.

Preferred 6. Preferred compositions comprise a compound of component (a) mixed with a compound selected from (bl). More preferred is a composition wherein the compound of (bl) is mancozeb.

Preferred 7. Preferred compositions comprise a compound of component (a) mixed with a compound selected from (b2). More preferred is a composition wherein the compound of (b2) is famoxadone.

Preferred compositions comprise a compound of component (a) mixed with two compounds selected from two different groups selected from (bl), (b2), (b3), (b4), (b5), (b6), (b7), (b8) and (b9).

Preferred compositions are those wherein component (a) is selected from the compounds of Formula I preferred above.

Other fungicides that can be included in compositions of this invention in combination with a Formula I compound or as an additional component in combination with component (a) and component (b) are acibenzolar, benalaxyl, benomyl, blasticidin-S, Bordeaux mixture (tribasic copper sulfate), carpropamid, captafol, captan, carbendazim, chloroneb, chlorothalonil, copper oxychloride, copper salts such as copper sulfate and copper hydroxide, cyazofamid, cymoxanil, cyprodinil, (S)-3, 5-dichloro-N-(3-chloro-1-ethyl-1- methyl-2-oxopropyl) -4-methylbenzamide (RH 7281), diclocymet (S-2900), diclomezine, dicloran, dimethomorph, diniconazole-M, dodemorph, dodine, edifenphos, fencaramid (SZX0722), fenpiclonil, fentin acetate, fentin hydroxide, fluazinam, fludioxonil, flumetover (RPA 403397), flutolanil, folpet, fosetyl-aluminum, furalaxyl, furametapyr (S-82658), iprobenfos, iprodione, isoprothiolane, iprovalicarb, kasugamycin, mancozeb, maneb, mefenoxam, mepronil, metalaxyl, metiram-zinc, myclobutanil, neo-asozin (ferric methanearsonate), oxadixyl, pencycuron, prochloraz, procymidone, propamocarb, propineb, pyrifenox, pyrimethanil, pyroquilon, quinoxyfen, spiroxamine, sulfur, thifluzamide, thiophanate-methyl, thiram, triadimefon, tricyclazole, validamycin, vinclozolin, zineb and zoxamid.

Descriptions of the commercially available compounds listed above may be found in Te Pesticide Ma7lual, Twelfth Edition, C. D. S. Tomlin, ed. , British Crop Protection Council, 2000.

Of note are combinations of Formula I with fungicides of a different biochemical mode of action (e. g. mitochondrial respiration inhibition, inhibition of protein synthesis by interference of the synthesis of ribosomal RNA or inhibition of beta-tubulin synthesis) that can be particularly advantageous for resistance management. Examples include combinations of compounds of Formula I (e. g. Compound 1) with strobilurins such as azoxystrobin, kresoxim-methyl, pyraclostrobin and trifloxystrobin ; carbendazim, mitochondrial respiration inhibitors such as famoxadone and fenamidone; benomyl, cymoxanil ; dimethomorph ; folpet; fosetyl-aluminum ; metalaxyl; mancozeb and maneb.

These combinations can be particularly advantageous for resistance management, especially where the fungicides of the combination control the same or similar diseases.

Of note are combinations of Formula I with fungicides for controlling grape diseases (e. g. Plasmopara viticola, Botrytis cinerea and Uncinula necatur) including alkylenebis (dithiocarbamate) s such as mancozeb, maneb, propineb and zineb, phthalimids such as folpet, copper salts such as copper sulfate and copper hydroxide, strobilurins such as azoxystrobin, pyraclostrobin and trifloxystrobin, mitochondrial respiration inhibitors such as famoxadone and fenamidone, phenylamides such as metalaxyl, phosphonates such as fosetyl-Al, dimethomorph, pyrimidinone fungicides such as 6-iodo-3-propyl-2-propyloxy-4 (3H)-quinazolinone and 6-chloro-2-propoxy-3- propylthieno [2, 3-ellpyrimidin-4 (3f1)-one, and other fungicides such as cymoxanil.

Of note are combinations of Formula I with fungicides for controlling potato diseases (e. g. PhytopAthora nfestans, AlternalXia solani and Rhizoctonia sola7zi) including alkylenebis (dithiocarbamate) s such as mancozeb, maneb, propineb and zineb; copper salts such as copper sulfate and copper hydroxide ; strobilurins such as pyraclostrobin and trifloxystrobin; mitochondrial respiration inhibitors such as famoxadone and fenamidone; phenylamides such as metalaxyl; carbamates such as propamocarb; phenylpyridylamines such as fluazinam and other fungicides such as chlorothalonil, cyazofamid, cymoxanil, dimethomorph, zoxamid and iprovalicarb.

Of note are compositions wherein component (b) comprises at least one compound from each of two different groups selected from (bl), (b2), (b3), (b4), (b5), (b6), (b7), (b8) and (b9). The weight ratio of the compound (s) of the first of these two component (b) groups to the compound (s) of the second of these component (b) groups typically is from 100: 1 to 1: 100, more typically from 30: 1 to 1: 30 and most typically from 10: 1 to 1: 10.

Of note are compositions wherein component (b) comprises at least one compound selected from (bl), for example mancozeb, and at least one compound selected from a second component (b) group, for example, from (b2), (b3), (b6), (b7), (b8) or (b9). Of particular note are such compositions wherein the overall weight ratio of component (b) to component (a) is from 30 : 1 to 1: 30 and the weight ratio of component (bl) to component (a) is from 10: 1 to 1: 1. Included are compositions wherein the weight ratio of component (bl) to component (a) is from 9: 1 to 4.5 : 1. Examples of these compositions include compositions comprising mixtures of component (a) (preferably a compound from Index Table A and B) with mancozeb and a compound selected from the group consisting of famoxadone, fenamidone, azoxystrobin, kresoxim-methyl, pyraclostrobin, trifloxystrobin, cymoxanil, metalaxyl, benalaxyl, oxadixyl, 6-iodo-3-propyl-2-propyloxy-4 (3H)-quinazoRinone, 6- chloro-2-propoxy-3-propylthieno [2, 3-d] pyrimidin-4 (3H)-one, folpet, captan and fosetyl- aluminum.

Also of note are compositions wherein component (b) comprises at least one compound selected from (b2), for example famoxadone, and at least one compound selected from a second component (b) group, for example, from (bl), (b3), (b6), (b7), (b8) or (b9). Of particular note are such compositions wherein the overall weight ratio of component (b) to component (a) is from 30: 1 to 1: 30 and the weight ratio of component (b2) to component (a) is fi-om 10: 1 to 1: 1. Included are compositions wherein the weight ratio of component (b2) to component (a) is from 9: 1 to 4.5 : 1. Examples of these compositions include compositions comprising mixtures of component (a) (preferably a compound from Index Table A and B) with famoxadone and a compound selected from the group consisting of mancozeb, maneb, propineb, zineb, cymoxanil, metalaxyl, benalaxyl, oxadixyl, 6-iodo-3-propyl-2-propyloxy- 4 (3H)-quinazolinone, 6-chloro-2-propoxy-3-propylthieno [2, 3-aQpyrimidin-4 (3H)-one, folpet, captan and fosetyl-aluminum.

Also of note are compositions wherein component (b) comprises the compound of (b3), in other words cymoxanil, and at least one compound selected from a second component (b) group, for example, from (bl), (b2), (b6), (b7), (b8) or (b9). Of particular note are such compositions wherein the overall weight ratio of component (b) to component (a) is from 30: 1 to 1: 30 and the weight ratio of component (b3) to component (a) is from 10: 1 to 1: 1. Included are compositions wherein the weight ratio of component (b3) to component (a) is from 9: 1 to 4.5 : 1. Examples of these compositions include compositions comprising mixtures of component (a) (preferably a compound from Index Table A and B) with cymoxanil and a compound selected from the group consisting of famoxadone, fenamidone, azoxystrobin, kresoxim-methyl, pyraclostrobin, trifloxystrobin, mancozeb, maneb, propineb, zineb, metalaxyl, benalaxyl, oxadixyl, 6-iodo-3-propyl- 2-propyloxy-4 (3H)-quinazolinone, 6-chloro-2-propoxy-3-propylthieno [2, 3-d] pyrimidin- 4 (3H)-one, folpet, captan and fosetyl-aluminum.

Also of note are compositions wherein component (b) comprises at least one compound selected from (b6), for example metalaxyl, and at least one compound selected from a second component (b) group, for example, from (bl), (b2), (b3), (b7), (b8) or (b9).

Of particular note are such compositions wherein the overall weight ratio of component (b) to component (a) is from 30: 1 to 1: 30 and the weight ratio of component (b6) to component (a) is from 10: 1 to 1: 3. Included are compositions wherein the weight ratio of component (b6) to component (a) is from 9: 1 to 4.5 : 1. Examples of these compositions include compositions comprising mixtures of component (a) (preferably a compound from Index Table A and B) with metalaxyl or oxadixyl and a compound selected from the group consisting of famoxadone, fenamidone, azoxystrobin, kresoxim-methyl, pyraclostrobin, trifloxystrobin, cymoxanil, mancozeb, maneb, propineb, zineb, 6-iodo-3-propyl- 2-propyloxy-4 (3I)-quinazolinone, 6-chloro-2-propoxy-3-propylthieno [2, 3-d] pyrin-iidin- 4 (3H)-one, folpet, captan and fosetyl-aluminum.

Also of note are compositions wherein component (b) comprises at least one compound selected from (b7), for example 6-iodo-3-propyl-2-propyloxy-4 (3H)- quinazolinone or 6-chloro-2-propoxy-3-propylthieno [2, 3-d] pyrimidin-4 (3H)-one, and at least one compound selected from a second component (b) group, for example, from (bl), (b2), (b3), (b6), (b8) or (b9). Of particular note are such compositions wherein the overall weight ratio of component (b) to component (a) is from 30: 1 to 1: 30 and the weight ratio of component (b7) to component (a) is from 1 : 1 to 1: 20. Included are compositions wherein the weight ratio of component (b6) to component (a) is from 1: 4.5 to 1: 9. Examples of these compositions include compositions comprising mixtures of component (a) (preferably a compound from Index Table A and B) with 6-iodo-3-propyl-2-propyloxy-4 (3H)- quinazolinone or 6-chloro-2-propoxy-3-propylthieno [2, 3-4pyrimidin-4 (3W)-one and a compound selected from the group consisting of famoxadone, fenamidone, azoxystrobin, kresoxim-methyl, pyraclostrobin, trifloxystrobin, cymoxanil, mancozeb, maneb, propineb, zineb, metalaxyl, benalaxyl, oxadixyl, folpet, captan and fosetyl-aluminum.

Also of note are compositions wherein component (b) comprises the compound of (b9), in other words fosetyl-aluminum, and at least one compound selected from a second component (b) group, for example, from (bl), (b2), (b3), (b6) or (b7). Of particular note are such compositions wherein the overall weight ratio of component (b) to component (a) is from 30: 1 to 1: 30 and the weight ratio of component (b9) to component (a) is from 10: 1 to 1: 1. Included are compositions wherein the weight ratio of component (b9) to component (a) is from 9: 1 to 4.5 : 1. Examples of these compositions include compositions comprising mixtures of component (a) (preferably a compound from Index Table A and B) with fosetyl- aluminum and a compound selected from the group consisting of famoxadone, fenamidone, azoxystrobin, kresoxim-hethyl, pyraclostrobin, trifloxystrobin, mancozeb, maneb, propineb, zineb, metalaxyl, benalaxyl, oxadixyl, 6-iodo-3-propyl-2-propyloxy-4 (3. H)-quinazolinone, 6- chloro-2-propoxy-3-propylthieno [2, 3-d] pyrimidin-4 (3H)-one, folpet, captan and cymoxanil.

Of note are combinations of compounds of Formula I with fungicides giving an even broader spectrum of agricultural protection including strobilurins such as azoxystrobin, kresoxim-methyl, pyraclostrobin and trifloxystrobin ; morpholines such as fenpropidine and fenpropimorph; triazoles such as bromuconazole, cyproconazole, difenoconazole, epoxyconazole, flusilazole, ipconazole, metconazole, propiconazole, tebuconazole and triticonazole; pyrimidinone fungicides, benomyl ; carbendazim ; chlorothalonil; dimethomorph; folpet; mancozeb; maneb; quinoxyfen; validamycin and vinclozolin.

Of particular note are combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with azoxystrobin, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with kresoxim-methyl, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with pyrclostrobin, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with trifloxystrobin, combinations of Compound 3,

Compound 4, Compound 5 or Compound 6 with carbendazim, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with chlorothalonil, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with dimethomorph, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with folpet, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with mancozeb, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with maneb, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with quinoxyfen, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with validamycin, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with vinclozolin, Compound 3, Compound 4, Compound 5 or Compound 6 with fenpropidine, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with fenpropimorph, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with bromuconazole, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with cyproconazole, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with difenoconazole, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with epoxyconazole, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with flusilazole, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with ipconazole, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with metconazole, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with propiconazole, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with tebuconazole, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with triticonazole, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with famoxadone, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with fenamidone, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with benomyl, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with cymoxanil, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with fosetyl-aluminum, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with metalaxyl, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with propineb, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with zineb, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with copper sulfate, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with copper hydroxide, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with propamocarb, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with cyazofamid, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with zoxamid, combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with fluazinam and combinations of Compound 3, Compound 4, Compound 5 or Compound 6 with iprovalicarb. Compound numbers refer to compounds in Index Table A and B.

Fonnulation/Utility Compositions of this invention will generally be used as a formulation or composition comprising at least one carrier selected from agriculturally suitable liquid diluents, solid diluents and surfactants. The formulation or composition ingredients are selected to be consistent with the physical properties of the active ingredient, mode of application and environmental factors such as soil type, moisture and temperature. Useful formulations include liquids such as solutions (including emulsifiable concentrates), suspensions, emulsions (including microemulsions and/or suspoemulsions) and the like which optionally can be thickened into gels. Useful formulations further include solids such as dusts, powders, granules, pellets, tablets, films, and the like which can be water-dispersible ("wettable") or water-soluble. Active ingredient can be (micro) encapsulated and further formed into a suspension or solid formulation; alternatively the entire formulation of active ingredient can be encapsulated (or"overcoated"). Encapsulation can control or delay release of the active ingredient. Sprayable formulations can be extended in suitable media and used at spray volumes from about one to several hundred liters per hectare. High-strength compositions are primarily used as intermediates for further formulation.

The formulations will typically contain effective amounts (e. g. from 0.01-99. 99 weight percent) of active ingredients together with diluent and/or surfactant within the following approximate ranges which add up to 100 percent by weight.

Weight Percent Active Ingredieuts Diluent Surfactant Water-Dispersible and Water-soluble 5-90 0-94 1-15 Granules, Tablets and Powders.

Suspensions, Emulsions, Solutions 5-50 40-95 0-25 (including Emulsifiable Concentrates) Dusts 1-25 70-99 0-5 Granules and Pellets 0.01-99 5-99. 99 0-15 High Strength Compositions 90-99 0-10 0-2 Typical solid diluents are described in Watkins, et al., Handbook of Ifzsecticide Dust Diluents and Carriers, 2nd Ed. , Dorland Books, Caldwell, New Jersey. Typical liquid diluents are described in Marsden, Solvents Guide, 2nd Ed., Interscience, New York, 1950.

McCutcheon's Detergents and E7nulsifiers An7lual, Allured Publ. Corp. , Ridgewood, New Jersey, as well as Sisely and Wood, Encyclopedig ofSu7face Active Agents, Chemical Publ.

Co. , Inc., New York, 1964, list surfactants and recommended uses. All formulations can contain minor amounts of additives to reduce foam, caking, corrosion, microbiological growth and the like, or thickeners to increase viscosity.

Surfactants include, for example, polyethoxylated alcohols, polyethoxylated alkylphenols, polyethoxylated sorbitan fatty acid esters, dialkyl sulfosuccinates, alkyl sulfates, alkylbenzene sulfonates, organosilicones, NN-dialkyltaurates, lignin sulfonates, naphthalene sulfonate formaldehyde condensates, polycarboxylates, and polyoxyethylene/polyoxypropylene block copolymers. Solid diluents include, for example, clays such as bentonite, montmorillonite, attapulgite and kaolin, starch, sugar, silica, talc, diatomaceous earth, urea, calcium carbonate, sodium carbonate and bicarbonate, and sodium sulfate. Liquid diluents, include, for example, water, N, N-dimethylformamide, dimethyl sulfoxide, N-alkylpymolidone, ethylene glycol, polypropylene glycol, paraffins, allcylbenzenes, allcylnaphthalenes, oils of olive, castor, linseed, tung, sesame, corn, peanut, cotton-seed, soybean, rape-seed and coconut, fatty acid esters, ketones such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4-methyl-2-pentanone, and alcohols such as methanol, cyclohexanol, decanol and tetrahydrofurfuryl alcohol.

Solutions, including emulsifiable concentrates, can be prepared by simply mixing the ingredients. Dusts and powders can be prepared by blending and, usually, grinding as in a hammer mill or fluid-energy mill. Suspensions are usually prepared by wet-milling ; see, for example, U. S. 3,060, 084. Preferred suspension concentrates include those containing, in addition to the active ingredient, from 5 to 20% nonionic surfactant (for example, polyethoxylated fatty alcohols) optionally combined with 50-65% liquid diluents and up to 5% anionic surfactants. Granules and pellets can be prepared by spraying the active material upon preformed granular carriers or by agglomeration techniques. See Browning, "Agglomeration", Chemical Engineering, December 4,1967, pp 147-48, Penny's Chemical Engineer's Handbook, 4th Ed., McGraw-Hill, New York, 1963, pages 8-57 and following, and WO 91/13546. Pellets can be prepared as described in U. S. 4,172, 714.

Water-dispersible and water-soluble granules can be prepared as taught in U. S. 4,144, 050, U. S. 3,920, 442 and DE 3,246, 493. Tablets can be prepared as taught in U. S. 5,180, 587, U. S.

5, 232, 701 and U. S. 5,208, 030. Films can be prepared as taught in GB 2,095, 558 and U. S.

3,299, 566.

For further information regarding the art of formulation, see U. S. 3,235, 361, Col. 6, line 16 through Col. 7, line 19 and Examples 10-41 ; U. S. 3, 309, 192, Col. 5, line 43 through Col. 7, line 62 and Examples 8,12, 15,39, 41, 52, 53,58, 132,138-140, 162-164,166, 167 and 169-182 ; U. S. 2,891, 855, Col. 3, line 66 through Col. 5, line 17 and Examples 1-4; Klingman, Weed Control as a Science, John Wiley and Sons, Inc., New York, 1961, pp 81-96; and Hance et al., Weed Control HandbooAc, 8th Ed. , Blackwell Scientific Publications, Oxford, 1989.

In the following Examples, all percentages are by weight and all formulations are prepared in conventional ways. Without further elaboration, it is believed that one skilled in the art using the preceding description can utilize the present invention to its fullest extent.

The following Examples are, therefore, to be construed as merely illustrative, and not limiting of the disclosure in any way whatsoever. Percentages are by weight except where otherwise indicated.

Example A Wettable Powder Active ingredients 65.0% dodecylphenol polyethylene glycol ether 2.0% sodium lignitsulfonate 4.0% sodium silicoaluminate 6.0% montmorillonite (calcined) 23.0%.

Example B Granule Active ingredients 10.0% attapulgite granules (low volatile matter, 0. 71/0. 30 mm; U. S. S. No. 25-50 sieves) 90. 0%.

Example C Extruded Pellet Active ingredients 25. 0% anhydrous sodium sulfate 10. 0% crude calcium ligninsulfonate 5.0% sodium alkylnaphthalenesulfonate 1. 0% calcium/magnesium bentonite 59. 0%.

Example D Emulsifiable Concentrate Active ingredients 20.0% blend of oil soluble sulfonates and polyoxyethylene ethers 10.0% isophorone 70. 0%.

Example E Suspension Concentrate Active ingredients 20. 0% polyethoxylated fatty alcohol nonionic surfactant 15.0% ester derivative of montan wax 3. 0% calcium lignosulfonate anionic surfactant 2.0% polyethoxylated/polypropoxylated polyglycol block copolymer surfactant 1. 0%

propylene glycol diluent 6.4% poly (dimethylsiloxane) antifoam agent 0. 6% antimicrobial agent 0. 1 % water diluent 51.9% The formulation ingredients are mixed together as a syrup, the active ingredients are added and the mixture is homogenized in a blender. The resulting slurry is then wet-milled to form a suspension concentrate.

Compositions of this invention can also be mixed with one or more insecticides, nematocides, bactericides, acaricides, growth regulators, chemosterilants, semiochemicals, repellents, attractants, pheromones, feeding stimulants or other biologically active compounds to form a multi-component pesticide giving an even broader spectrum of agricultural protection. Examples of such agricultural protectants with which compositions of this invention can be formulated are: insecticides such as abamectin, acephate, azinphos-methyl, bifenthrin, buprofezin, carbofuran, chlorfenapyr, chloipyrifos, chlorpyrifos-methyl, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, deltamethrin, diafenthiuron, diazinon, diflubenzuron, dimethoate, esfenvalerate, fenoxycarb, fenpropathrin, fenvalerate, fipronil, flucythrinate, tau-fluvalinate, fonophos, imidacloprid, isofenphos, malathion, metaldehyde, methamidophos, methidathion, methyl, methoprene, methoxychlor, methyl 7-chloro-2, 5-dihydro-2-[[N-(methoxycarbonyl)-N-[4- (trifluoromethoxy) phenyl] amino] carbonyl] indeno [1, 2-e] [1, 3,4] oxadiazine-4a (3H)- carboxylate (indoxacarb), monocrotophos, oxamyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, rotenone, sulprofos, tebufenozide, tefluthrin, terbufos, tetrachlorvinphos, thiodicarb, tralomethrin, trichlorfon and triflumuron ; bactericides uch as streptomycin; acaricides such as amitraz, chinomethionat, chlorobenzilate, cyhexatin, dicofol, dienochlor, etoxazole, fenazaquin, fenbutatin oxide, fenpropathlin, fenpyroximate, hexythiazox, propargite, pyridaben and tebufenpyrad ; nematocides such as aldoxycarb and fenamiphos; and biological agents such as Bacillus thuringiensis, Bacillus thuringiensis delta endotoxin, baculovirus, and entomopathogenic bacteria, virus and fungi. The weight ratios of these various mixing partners to compounds of Formula I of this invention typically are between 100: 1 and 1: 100, preferably between 30 : 1 and 1: 30, more preferably between 10: 1 and 1: 10 and most preferably between 4: 1 and 1: 4.

The compounds and compositions of this invention are useful as plant disease control agents. The present invention therefore further comprises a method for controlling plant diseases caused by fungal plant pathogens comprising applying to the plant or portion thereof to be protected, or to the plant seed or seedling to be protected, an effective amount of a compound of the invention or a fungicidal composition containing said compound.

The preferred methods of use are those involving the compounds or compositions preferred above.

The compounds and compositions of this invention provide control of diseases caused by a broad spectrum of fungal plant pathogens in the Basidiomycete, Ascomycete, Oomycete and Deuteromycete classes. They are effective in controlling a broad spectrum of plant diseases, particularly foliar pathogens of ornamental, vegetable, field, cereal, and fruit crops.

These pathogens include Plasmopara viticola, Playtophthora infestans, Perosiospora tabacina, Pseudoperonospora cubensis, Pythium aphanidermatum, Alternaria brassicae, Septoria nodorum, Septoria tritici, Cercosporidium personatum, Cercospora arachidicola, Pseudocercosporella herpotrichoides, Cercospora beticola, Botrytis cinerea, Monilinia fi-ucticola, Pyricularia oryzae, Podosphaera leucotricha, Venturia inaequalis, Eiysiphe graminis, Uncinula necatur, Puccinia recondita, Puccinia graminis, Hemileia vastatrix, Puccinia strEiformis, Puccinia afachidis, Rlaizoctonia solani, Sphaerotheca fuliginea, Fusarium71 oxysporum, erticillium dahliae, Pythium aphanide7natum, Phytophthora megasperma, Sclerotinia sclerotiorum, Sclerotium rolfsEi, E7ysiphe polygoni, P) renophora teres, Gaeumannomyces graminis, Rynchosporium secalis, Fusarium roseum, Bremia lactucae and other generea and species closely related to these pathogens. The compositions of the invention are especially effective in controlling Plasmopara viticola on grapes and Pliytophthora infestans on potatoes and tomatoes.

Plant disease control is ordinarily accomplished by applying an effective amount of a compound of this invention either pre-or post-infection, to the portion of the plant to be protected such as the roots, stems, foliage, fruit, seeds, tubers or bulbs, or to the media (soil or sand) in which the plants to be protected are growing. The compounds can also be applied to the seed to protect the seed and seedling.

Rates of application for these compounds can be influenced by many factors of the environment and should be determined under actual use conditions. Foliage can normally be protected when treated at a rate of from less than 1 g/ha to 5,000 g/ha of active ingredient.

Seed and seedlings can normally be protected when seed is treated at a rate of from 0.1 to 10 g per kilogram of seed.

The following TESTS demonstrate the control efficacy of compounds of this invention on specific pathogens. The pathogen control protection afforded by the compounds is not limited, however, to these species. See Index Table A-C for compound descriptions. The abbreviation"Me"stands for"methyl". The abbreviation"Ex. "stands for"Example"and is followed by a number indicating in which example the compound is prepared. The symbol "--"means there is no substituent corresponding to that group.

INDEX TABLE A Compound Number Rl R2 (R5)m R6a K (R7)n R6b m.p.(°C.) 1 H H 3-C1-5-CF3 Cl K-38--a * 2 H H 3-C1-5-CF3 Cl K-2--Cl 158-160 3 (Ex. 1) H H 3-C1-5-CF3 Cl K-40--Cl 48-50 INDEX TABLE B

Compound Number Rl R2 (R5)m R6a K (R7)n R6b m. p. (°C.) 4 H Me 3-Cl-5-Br Cl K-38--H * 5 H Me 3-Cl-5-Br Br K-38--H * 6 H Me 3-Cl-5-Br F K-38--H * *See Index Table B for 1H NMR data.

INDEX TABLE C Cmpd No. 1H NMR Data (300mHz ; CDCl3 solution unless indicated otherwise) 3 b 8.69 (1H, s), 8.26 (1H, d, J=8 Hz), 8.09 (1H, d, J=8 Hz), 8. 01 (1H, s), 7.87 (1H, t, J=8 Hz), 7.73 (1H, t, J=8 Hz), 7.59 (1H, br s), 5.04 (2H, d, J=4 Hz).

4 8 9.09 (s, 1H), 8.46 (s, 1H), 8. 00 (d, 1H), 7.92 (d, 1H), 7.89 (d, 1H), 7.75 (m, 1H), 7.64 (m, 1H), 7.49 (bd, 1H), 5.87 (m, 1H), 1.66 (d, 3H).

5 8 9.05 (s, 1H), 8. 46 (s, 1H), 8.00 (d, 1H), 7.92 (d, 1H), 7.87 (d, 1H), 7.75 (m, 1H), 7.66 (m, 1H), 7.46 (bd, 1H), 5.88 (m, 1H), 1.67 (d, 3H).

6 8 9.01 (s, 1H), 8.50 (s, 1H), 8.28 (d, 1H), 8. 02 (d, 1H), 7.92 (d, 1H), 7.77 (m, 1H), 7.66 (bd, 1H), 7.62 (m, 1H), 5.85 (m,1H), 1.63 (d, 3H).

BIOLOGICAL EXAMPLES OF THE INVENTION General protocol for preparing test suspensions: Test compounds are first dissolved in acetone in an amount equal to 3% of the final volume and then suspended at the desired concentration (in ppm) in acetone and purified water (50/50 mix) containing 250 ppm of the surfactant Trem (E) 014 (polyhydric alcohol esters). The resulting test suspensions are then used in the following tests. Spraying a 200 ppm test suspension to the point of run-off on the test plants is the equivalent of a rate of 500 g/ha.

TEST A The test suspension was sprayed to the point of run-off on wheat seedlings. The following day the seedlings are inoculated with a spore dust of Erysiphe gi^arninis f. sp. tritici, (the causal agent of wheat powdery mildew) and incubated in a growth chamber at 20 °C for 7 days, after which disease ratings are made.

TEST B The test suspension was sprayed to the point of run-off on wheat seedlings. The following day the seedlings are inoculated with a spore suspension of Puccinia recondita (the causal agent of wheat leaf rust) and incubated in a saturated atmosphere at 20 °C for 24 h, and then moved to a growth chamber at 20 °C for 6 days, after which disease ratings are made.

TEST C The test suspension was sprayed to the point of run-off on potato seedlings. The following day the seedlings are inoculated with a spore suspension of Phytophthora infestans (the causal agent of tomato and potato late blight) and incubated in a saturated atmosphere at 20°C for 24 h, and then moved to a growth chamber at 20°C for 5 days, after which disease ratings are made.

TEST D The test suspension was sprayed to the point of run-off on tomato seedlings. The following day the seedlings are inoculated with a spore suspension of Phytophtliora ilifestans (the causal agent of tomato and potato late blight) and incubated in a saturated atmosphere at 20°C for 24 h, and then moved to a growth chamber at 20°C for 5 days, after which disease ratings are made.

TEST E The test suspension was sprayed to the point of run-off on grape seedlings. The following day the seedlings are inoculated with d spore suspension of Plasmopara viticola (the causal agent of grape downy mildew) and incubated in a saturated atmosphere at 20 °C for 24 h, moved to a growth chamber at 20 °C for 6 days, and then incubated in a saturated atmosphere at 20 °C for 24 h, after which disease ratings are made.

TEST F Potato seedlings are inoculated with a spore suspension of PhytopAtora i71festans (the causal agent of potato and tomato late blight) and incubated in a saturated atmosphere at 20 °C for 24 h. The next day, test suspension is sprayed to the point of run-off and the treated plants are moved to a growth chamber at 20 °C for 5 days, after which disease ratings are made.

TEST G Grape seedlings are inoculated with a spore suspension of Plasmopara viticola (the causal agent of grape downy mildew) and incubated in a saturated atmosphere at 20 °C for 24 h. The next day, test suspension is sprayed to the point of run-off and the treated plants are moved to a growth chamber at 20 °C for 6 days, and then incubated in a saturated atmosphere at 20 °C for 24 h, after which disease ratings are made.

Results for Tests A-G are given in Table A. In the table, a rating of 100 indicates 100% disease control and a rating of 0 indicates no disease control (relative to the controls).

A dash (-) indicates no test results.

Table A Cmpd No. Test A Test B Test C Test D Test E Test F Test G 1 0 0 98** 97 99** 0** 15 2 0 0 100** 100 100** 93** 13 3 0 0 100** 100 100** 0** 100 4 0-100** 100 100** 0** 100 5 0-100** 100 100** 85** 92 6 0 - 100** 100 100** 24** 96 ** tested at 100 ppm